Page 2


  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

  • An illustration of stacked glowing silhouettes.
    Image attribution tooltip

    Illustration: Matthieu Bourel for Industry Dive

    PharmaVoice 100

    The 2022 PharmaVoice 100

    From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Profile // Red Jacket honorees 2022

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

  • A portrait of Dr. Jordan Schecter framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jordan Schecter
    Profile // PharmaVoice 100

    Innovators: Dr. Jordan Schecter

    The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.

  • A portrait of Sastry Chilukuri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sastry Chilukuri
    Profile // PharmaVoice 100

    Tech Wizards: Sastry Chilukuri

    The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.

  • A portrait of Laxmi Bonagiri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laxmi Bonagiri
    Profile // PharmaVoice 100

    DE&I Champions: Laxmi Bonagiri

    EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.

  • A portrait of Scott Gray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Scott Gray
    Profile // PharmaVoice 100

    DE&I Champions: Scott Gray

    The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.

  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Profile // Red Jacket honorees 2022

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Profile

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

  • A portrait of Rosalind Brewer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rosalind Brewer
    Profile // PharmaVoice 100

    Disrupters: Rosalind Brewer

    The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.

  • A portrait of Jennifer Gottlieb framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jennifer Gottlieb
    Profile // PharmaVoice 100

    DE&I Champions: Jennifer Gottlieb

    The global president and chief client officer of Real Chemistry is dedicated to ensuring all voices at the agency are heard and everyone has a seat at the table.

  • A portrait of Otis Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Otis Johnson
    Profile // PharmaVoice 100

    DE&I Champions: Otis Johnson

    Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices. 

  • A portrait of Carl Turner framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carl Turner
    Profile // PharmaVoice 100

    Disrupters: Carl Turner

    How Klick’s first-ever chief brand strategy officer is relying on collaboration to advance innovative strategies for clients and opportunities for people of color.

  • A portrait of Johnna Wesley framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Johnna Wesley
    Profile // PharmaVoice 100

    Innovators: Johnna Wesley

    The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.

  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Profile // Red Jacket honorees 2022

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

  • A portrait of David Katz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by David Katz
    Profile // PharmaVoice 100

    Entrepreneurs: David Katz

    As the founder and chief scientific officer of Sparrow Pharmaceuticals, David Katz is breathing new life into drugs that have previously been shelved.

  • A portrait of Nello Mainolfi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nello Mainolfi
    Profile // PharmaVoice 100

    Entrepreneurs: Nello Mainolfi

    Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.

  • A portrait of Kathy Lee-Sepsick framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kathy Lee-Sepsick
    Profile // PharmaVoice 100

    Entrepreneurs: Kathy Lee-Sepsick

    Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.

  • A portrait of Samantha Du framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Du
    Profile // PharmaVoice 100

    Entrepreneurs: Samantha Du

    The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.

  • A portrait of Dawn Berry framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dawn Berry
    Profile // PharmaVoice 100

    Entrepreneurs: Dawn Barry

    The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.

  • Methadone at home
    Image attribution tooltip
    Stock via Getty Images

    Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

    Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

  • Katharine Knobil
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil

    As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.

  • Colonies of bacteria in MacConkey agar
    Image attribution tooltip
    Md Saiful Islam Khan via Getty Images

    Feds could soon bring COVID-style fight to superbug threat

    COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.

  • Bubble
    Image attribution tooltip
    Petrovich9 via Getty Images

    From the ‘go-go days’ to a bubble crunch — the biotech sector faces its next challenge

    The highs of the sector in early 2021 gave way to a bear market that persisted into the second half of this year — but there's hope the bubble hasn't popped for good.